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DNA methylation is one of the most studied 
epigenetic modifications and is essential for mammalian 
development. The methylation pattern is established 
through an extremely orchestrated mechanism that 
implicates de novo methylation, maintenance of 
the methylated cytosine, and demethylation. DNA 
methylation is catalyzed by the well-characterized DNA 
methyltransferase family enzymes (DNMTs), including 
the DNMT3A and DNMT3B that are responsible 
for the de novo methylation and DNMT1 that is the 
mediator of the maintenance of the DNA methylation 
pattern through cell replication [1]. In contrast, the 
mechanisms by which removal of DNA methylation 
occurs remained elusive, until recently when it has been 
proposed an active mechanism of DNA demethylation 
involving ten-eleven translocation methylcytosine 
dioxygenase (TET) and thymine DNA glycosylase 
(TDG) proteins [2]. The rules that govern the dynamics 
of DNA methylation/demethylation have not yet been 
clarified and represent a key need to deeply understand 
both normal development and diseases. The first step 
toward a deeper comprehension of the role of 5mC 
and its oxidized derivatives is the mapping of such 
modifications on a genome-wide scale. In a recent report, 
we presented a novel high-throughput method, named 
Methylation Assisted Bisulfite sequencing (MAB-seq) 
[3], that enables genome-wide mapping at single-base 
resolution, and quantitation, of 5fC/5caC residues. MAB-
seq is based on the protection of unmethylated cytosines 
through an in vitro methylation treatment, followed by 
bisulfite conversion, which results in the deamination of 
only 5fC/5caC residues. Major strength of MAB-seq is 
the ability to directly map with a single treatment, and 
in a single sequencing run both 5fC/5caC intermediate 
products of cytosine demethylation, reducing the need 
for a higher coverage, typical of subtractive methods 
[2], and the risk of introducing false positives. Mapping 
the 5fC/5caC distribution across the genome of mouse 
embryonic stem cells (ESCs) revealed a strong enrichment 
of these modifications on enhancers, exons, and repetitive 
regions, in agreement with previous reports based on 
affinity purification methods [4, 5]. Surprisingly, MAB-
seq also revealed a strong enrichment of 5fC/5caC on 
active promoters, especially on the transcriptional start 
sites (TSSs) of actively transcribed genes marked by 
H3K4me3. This enrichment, and the consequent depletion 
of 5mC/5hmC marks, becomes more pronounced with 
the increased level of promoter accessibility, and reveals 
the existence of active methylation/demethylation cycles 
occurring on active promoters. As additional evidence, 
ChIP-seq analysis of Tdg revealed strong co-occupancy 
of Tdg and Tet1 on the TSSs of H3K4me3 gene promoters, 
and knockdown of TDG resulted in a significant increase 
of 5fC/5caC levels on the TSSs of actively transcribed 
genes. 
Moreover, Tet1/2 double knockdown increases the 
5mC level on the TSSs of actively transcribed genes, 
whereas Dnmt1 and Dnmt3a, but not Dnmt3b, knockdown 
leads to a significant reduction of the methylated cytosine. 
All together, these data suggest the existence of an 
articulate circuitry involving Dnmt1/3a, Tet1/2, and Tdg 
proteins, aimed to maintaining the hypomethylated state of 
the promoter of the H3K4me3 genes in ESCs (Figure 1). 
This evidence shed new light on the mechanism 
of transcriptional gene repression mediated by the 
DNA methylation. It has been proposed that promoter 
of highly expressed genes are free from the action of 
the DNMTs, probably thanks to the inhibitory function 
of the H3K4me3 and to the steric hindrance of the 
transcriptional factors. Our result show for the first time 
that DNA methylation events can occur on the promoters 
of the open genes, but they are rapidly eliminated 
by an active DNA demethylation mechanism. These 
observations demonstrate that the DNA methylation is 
an epigenetic feature more flexible and dynamic than 
previously thought and highlight the importance of TET 
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Figure 1: Promoter DNA methylation dynamics. 
H3K4me3 active promoters undergo to DNA methylation and 
demethylation processes mediated by DNMTs and TET/TDG 
enzymes.
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and TDG proteins in the regulation of active genes with 
both physiological and pathological implications [6]. 
Indeed, specific gene promoters’ hypermethylation that 
characterizes differentiated cells and several diseases 
could be mediated by loss of the mechanism of active 
(protective) demethylation rather than targeted de novo 
DNA methylation. The involvement of Dnmt1 in this 
(sporadic) DNA methylation of the active gene promoters 
suggests that, in this context, Dnmt1 could make de novo 
methylation as previously observed [7]. 
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